Moderna: From Breakthrough COVID-19 Vaccines To Personalised Cancer Therapies
This article was written byFollowOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineerings, and +20 years experience in the research...
Moderna
Moderna forecasts lower sales next year, shares near four-year low By Reuters
By Patrick Wingrove (Reuters) -Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline...
